• Search
  • Login
  • Register
Menu
  • Last issue
  • Home
  • News
  • CongressUpdate
  • Guidelines
  • Specials
  • Links
  • Reimbursement News
All
  • All
  • BJH articles
  • Blog articles
  • Specials
Forgot Password? Not a member yet? Register here
News > Clinical trials

Category

All
  • General
  • Healthy Living
  • Pharma News
  • Health of Tomorrow
  • Viewpoints
  • Art Corner
  • Fundraising
  • Prevention
  • Science
  • Clinical trials
  • Clinical practice
  • Corona
  • Medical Research
  • Health Innovation
  • Art on View
  • Podcasts
  • Therapy
  • Editor's pick
  • Covid-19
  • Society Announcement
  • Reimbursement News
  • Congress News

Specialty

All
  • Alle
  • YESCARTA
  • BEKEMV
  • NPLATE

Clinical trials

Emicizumab prophylaxis is efficient and safe for infants with haemophilia A

Read more
subscribe Latest issue All issues Newsletters
Index latest issue
  • INTRODUCTION
  • Advancements in thrombophilia testing: The role of multi-gene panels in venous thromboembolism
  • The role of UBTF-TD mutations in paediatric acute myeloid leukaemia and myelodysplastic syndrome
  • Desensitisation as treatment option in patients with drug hypersensitivity
  • HMB-001: Novel treatment for Glanzmann thrombasthenia
  • Anti-IL6 receptor antibody for the treatment of immune checkpoint-related hemophagocytic lymphohistiocytosis
  • Highlights from EBMT 2025
  • Journal scan
  • New haematology reimbursements in Belgium
Clinical trials

Global harmonisation of haemoglobin thresholds for anaemia diagnosis

Read more
Clinical trials

Venetoclax monotherapy leads to durable responses in R/R chronic lymphocytic leukaemia patient...

Read more
Clinical trials

Immunoglobulin gene rearrangement test for bone marrow involvement in cases of DLBCL

Read more
Clinical trials

Efficacy of tabelecleucel in R/R EBV-positive post-transplant lymphoproliferative disease

Read more
Clinical trials

MRD-guided ibrutinib and venetoclax regimen improves PFS in CLL patients

Read more
Clinical trials

Adding Isa to Kd improves outcomes in multiple myeloma, regardless of the time of relapse

Read more
Clinical trials

Golidocitinib shows promising results in patients with refractory/relapsed peripheral T-cell l...

Read more
Clinical trials

Adding daratumumab to VRd results in improved PFS in multiple myeloma

Read more
Previous 1 2 3 4 5 6 7 Next
Top

Join our newsletter

  • This field is for validation purposes and should be left unchanged.
  • About BJH
  • Advertisements & sponsoring
  • Vacancies
  • Disclaimer
  • Privacy
  • Contact

BJH is published by Ariez International BV, Westzijde 22, 1506 EE Zaandam, The Netherlands

© BJH 2025